147 related articles for article (PubMed ID: 11355148)
1. Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.
Schiebe M; Ohneseit P; Hoffmann W; Meyermann R; Rodemann HP; Bamberg M
J Cancer Res Clin Oncol; 2001 May; 127(5):325-8. PubMed ID: 11355148
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic alterations in glioblastomas with oligodendroglial component.
Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U
Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
5. Use of horizontal ultrathin gel electrophoresis to analyze allelic deletions in chromosome band 11p15.5 in gliomas.
Newsham IF; Gorse KM; Rempel SA; Luckey J; Golden JB; Bögler O
Neuro Oncol; 2000 Jan; 2(1):1-5. PubMed ID: 11302248
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at 11p15 in malignant glioma.
Sonoda Y; Iizuka M; Yasuda J; Makino R; Ono T; Kayama T; Yoshimoto T; Sekiya T
Cancer Res; 1995 May; 55(10):2166-8. PubMed ID: 7743518
[TBL] [Abstract][Full Text] [Related]
7. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of TRIM3 in malignant gliomas.
Boulay JL; Stiefel U; Taylor E; Dolder B; Merlo A; Hirth F
BMC Cancer; 2009 Feb; 9():71. PubMed ID: 19250537
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.
Schiebe M; Ohneseit P; Hoffmann W; Meyermann R; Rodemann HP; Bamberg M
J Neurooncol; 2000 Sep; 49(3):197-203. PubMed ID: 11212898
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations of PTEN in glioblastoma multiforme.
Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
13. Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma.
Watanabe T; Hirota Y; Arakawa Y; Fujisawa H; Tachibana O; Hasegawa M; Yamashita J; Hayashi Y
Brain Pathol; 2003 Oct; 13(4):431-9. PubMed ID: 14655749
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.
Fujisawa H; Reis RM; Nakamura M; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 2000 Jan; 80(1):65-72. PubMed ID: 10653004
[TBL] [Abstract][Full Text] [Related]
17. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Ohgaki H; Kleihues P
J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients.
Kakkar A; Suri V; Jha P; Srivastava A; Sharma V; Pathak P; Sharma MC; Sharma MS; Kale SS; Chosdol K; Phalak M; Sarkar C
Neurol India; 2011; 59(2):254-61. PubMed ID: 21483128
[TBL] [Abstract][Full Text] [Related]
19. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]